Li W , Kim SM , Lee J , Dunphy WG .

	Figure 1. Xblm binds to chromatin and becomes phosphorylated in a checkpoint-dependent manner. (A) Extracts were incubated with no sperm chromatin (lane 1), untreated sperm chromatin (lane 2), sperm chromatin plus 100 μg/ml aphidicolin (APH; lane 3), UV-damaged sperm chromatin (lane 4), or sperm chromatin plus aphidicolin and caffeine (lane 5). After 90 min, nuclei were isolated and separated into nuclear soluble and chromatin fractions. The fractions were immunoblotted for Xblm and Xorc2 (as a loading control). (B) Extracts were incubated for 90 min with untreated sperm chromatin (lane 1), UV-damaged sperm chromatin (lane 2), or sperm chromatin plus aphidicolin (lane 3). Whole nuclear fractions were immunoblotted for Xblm. (C) Extracts were incubated with sperm chromatin alone (lane 1), sperm chromatin plus aphidicolin (lane 2), or sperm chromatin plus aphidicolin and caffeine (lane 3). Nuclear fractions were immunoblotted for Xblm. (D) Anti-Xblm immunoprecipitates from extracts containing no DNA (lane 1) or pA-pT (lanes 2 and 3) were incubated without (lanes 1 and 2) or with (lane 3) λ phosphatase and were immunoblotted for Xblm.
	Figure 2. Xatr and Xrad17, but not Claspin, are required for phosphorylation of Xblm. (A) Extracts were treated with control (lanes 1 and 2), anti-Xatr (lanes 3 and 4), or anti-Claspin (lanes 5 and 6) antibodies. Sperm chromatin was incubated in extracts for 90 min in the absence (lanes 1, 3, and 5) or presence (lanes 2, 4, and 6) of aphidicolin. Nuclear fractions were isolated and immunoblotted for Xatr, Claspin, Xblm, Xchk1, and P-Ser344 of Xchk1. (B) Extracts were treated with control (lanes 1, 2, 5, and 6) or anti-Xrad17 (lanes 3, 4, 7, and 8) antibodies. Sperm chromatin was incubated in extracts for 90 min in the absence (lanes 1 and 5) or presence (lanes 2–4 and 6–8) of aphidicolin. His6-Xrad17 was added back to some extracts (lanes 4 and 8). Chromatin fractions and whole-extract aliquots were immunoblotted for Xatr, Xblm, and Xrad17.
	Figure 3. Xblm is not required for the checkpoint-dependent phosphorylation of Xchk1 or Xchk2. (A) Untreated (lanes 1 and 2), Xblm-depleted (lanes 3 and 4), and mock-depleted (lanes 5 and 6) egg extracts containing 35S-labeled Xchk1 were incubated for 90 min in the absence or presence of aphidicolin. Nuclear fractions were isolated and immunoblotted for Xblm or were examined for phosphorylation of 35S-labeled Xchk1 by SDS-PAGE and phosphorimaging. (B) Extracts were treated with control antibodies (lanes 1 and 2), anti-Xblm antibodies (lanes 3 and 4), or no antibodies (lanes 5 and 6). 35S-labeled Xchk2 was incubated in these depleted extracts for 90 min in the absence or presence of pA-pT. 35S-labeled Xchk2 in the whole-egg extracts was examined by phosphorimaging. (C) Extracts were treated with control antibodies (lanes 1 and 2), anti-Xrad17 antibodies (lane 3), or both anti-Xrad17 and anti-Xblm antibodies (lane 4). Extracts were incubated with sperm chromatin in the absence (lane 1) or presence (lanes 2–4) of aphidicolin. Chromatin fractions were immunoblotted for Xatr, Xblm, and Xrad17. Phosphorylation of Xchk1 in the soluble nuclear fraction was detected with anti-P-Ser344 antibodies. (D) Extracts were treated with control (lanes 1 and 2), anti-Xrad17 (lane 3), or both anti-Xrad17 and anti-Xblm (lane 4) antibodies. Phosphorylation of 35S-labeled Xchk2 after incubation in the absence (lane 1) or presence (lanes 2–4) of pA-pT in egg extracts was examined.
	Figure 4. Xblm interacts with Xtop3α in a regulated manner. (A) Control (lane 1) and anti-Xblm (lanes 2 and 3) antibodies on protein A beads were incubated in extracts in the absence (lanes 1 and 2) or presence (lane 3) of pA-pT. The beads were collected and immunoblotted for Xblm and Xtop3α. (B) Control antibodies (lanes 1 and 4) and two different anti-Xblm antibodies (#870, lanes 2 and 5; #868, lanes 3 and 6) on protein A beads were incubated in extracts in the absence (lanes1–3) or presence (lanes 4–6) of pA-pT. The beads were collected and immunoblotted for Xtop3α. (C) His6-tagged Xblm-N122 on nickel beads and blank nickel beads were incubated in interphase egg extracts. The beads were collected and immunoblotted for Xtop3α. (D) Xblm-N122 on nickel beads was incubated in extracts containing no DNA (lane 1), pA-pT (lane 2), or pA-pT plus caffeine (lane 3). The beads were collected and immunoblotted with anti-Xtop3α and anti-His6 antibodies (to detect Xblm-N122). (E) Egg extracts were incubated with no DNA (lane 1), pA-pT (lane 2), or pA-pT plus caffeine (lane 3) and were immunoblotted for Xblm. (F) Anti-Xblm antibodies on protein A beads were incubated in extracts in the presence of different oligonucleotides. In some cases, either purified Xblm-N122 (lanes 6–10) or caffeine (lanes 11–14) was also added. After 2 h, the beads were collected and immunoblotted for Xblm and Xtop3α.
	Figure 5. The NH2-terminal 122 amino acids of Xblm are involved in the interaction with Xtop3α on chromatin. (A) Extracts were treated with no antibodies (lanes 1–3), anti-Xblm antibodies (lanes 4 and 5), or control antibodies (lanes 6 and 7) and then incubated with sperm chromatin alone (lanes 1, 4, and 6), sperm chromatin plus aphidicolin (lanes 2, 5, and 7), or sperm chromatin plus aphidicolin and caffeine (lane 3). After 90 min, nuclear fractions were isolated and separated into chromatin and nuclear soluble fractions. These fractions were immunoblotted for Xblm, Xtop3α, and Xorc2. (B) The NH2-terminal 122 amino acids of Xblm are required for interaction with Xtop3α on chromatin. Egg extracts containing sperm chromatin were incubated in the absence (lanes 1–4) or presence (lanes 5–8) of aphidicolin. The extracts were also treated without (lanes 1 and 5) or with (10–40 μg/μl; lanes 2–4 and 6–8) Xblm-N122. After 90 min, chromatin fractions were immunoblotted for Xblm, Xtop3α, and Xorc2. (C) Extracts were treated with no antibodies (lane 1), control antibodies (lane 2), or anti-Xtop3α antibodies (lane 3) and were immunoblotted for Xblm (top) and Xtop3α (bottom). (D) Mock-depleted extracts (lanes 1 and 2), Xtop3α- depleted extracts (lanes 3 and 4), and extracts treated with no antibodies (lanes 5 and 6) from C were incubated with sperm chromatin in the absence (lanes 1, 3, and 5) or presence (lanes 2, 4, and 6) of aphidicolin. Chromatin fractions were isolated and immunoblotted for Xblm, Xtop3α, and Xorc2.
	Figure 6. Phosphorylation of Xblm depends on association with Xtop3α. (A) Buffer alone (lanes 1 and 2) or Xblm-N122 (100 μg/μl; lanes 3 and 4) was added to extracts lacking (lanes 1 and 3) or containing (lanes 2 and 4) aphidicolin. After 90 min, nuclear fractions were isolated and immunoblotted with antibodies against Xblm and P-Ser344 of Xchk1. (B) Mock-depleted (lanes 1 and 2) and Xtop3α-depleted (lanes 3 and 4) extracts were incubated with sperm chromatin in the absence (lanes 1 and 3) or presence (lanes 2 and 4) of aphidicolin. After 90 min, nuclear fractions were isolated and immunoblotted with antibodies against Xblm, Xtop3α, and the whole Xchk1 protein.
	Figure 7. Xblm associates with replicating chromatin, but is not essential for DNA replication. (A) Sperm chromatin was incubated in egg extracts in the absence (lanes 1–5) or presence (lanes 6–10) of aphidicolin. At various times, chromatin fractions were isolated and immunoblotted for Xblm, RPA70, and Xorc2. (B) Xblm-depleted (lanes 1–4) and mock-depleted (lanes 5–8) egg extracts were incubated with sperm chromatin. Chromosomal DNA replication was assayed as described in the Materials and methods. The two bands in each lane depict 32P incorporation into chromosomal DNA. (C) Xblm-depleted (lanes 1 and 2) and mock-depleted (lanes 3 and 4) extracts were incubated with sperm chromatin in the absence (lanes 1 and 3) or presence (lanes 2 and 4) of aphidicolin. Chromatin fractions were isolated and immunoblotted for Xblm, RPA70, and Xorc2. (D) Mock-depleted (lanes 1 and 2) and RPA70-depleted (lanes 3 and 4) extracts were incubated with sperm chromatin in the absence (lanes 1 and 3) or presence (lanes 2 and 4) of aphidicolin. Chromatin fractions were isolated and immunoblotted for Xblm, RPA70, and Xorc2. (E) Extracts were left untreated (lane 1) or were treated with either geminin (lane 2) or p27 (lane 3) as described previously (Lee et al., 2003), and sperm chromatin was added. After 90 min, chromatin fractions were immunoblotted for Xblm (top) and Xorc2 (bottom).
	Figure 8. Xblm is required for preventing accumulation of chromosomal breaks during normal and disrupted S phases. (A) Extracts were treated with control antibodies (lanes 1–4), anti-Xblm antibodies (lanes 5–8), or no antibodies (lanes 9–12) and were incubated with sperm chromatin. Some extracts were treated with 0.1 U/μl EcoRI (lanes 9–12) and geminin (lanes 3, 4, 7, 8, 11, and 12). After 2 h, TUNEL assays were performed in the presence (lanes 2, 4, 6, 8, 10, and 12) or absence (lanes 1, 3, 5, 7, 9, and 11) of TdT. Samples were subjected to agarose gel electrophoresis and phosphorimaging (top). The radioactivity in each band was quantitated (bottom). (B) Mock-depleted (lane 1) and Xblm-depleted (lanes 2 and 3) extracts were prepared. Recombinant Xblm was made in the TnT® system and added back to an Xblm-depleted extract (lane 3). Samples were immunoblotted for Xblm. (C) Extracts were treated with control antibodies (lanes 1 and 7), anti-Xblm antibodies (lanes 2, 3, 8, and 9), or no antibodies (lanes 4, 5, 6, and 10) and were incubated with sperm chromatin. The reactions also contained 100 μg/ml Xblm-N122 (lanes 4 and 10), 0.1 U/μl EcoRI (lane 6), and aphidicolin (lanes 7–10). Full-length recombinant Xblm was added to some samples (lanes 3 and 9). After 2 h, TUNEL assays were performed as in A.

Ababou, ATM-dependent phosphorylation and accumulation of endogenous BLM protein in response to ionizing radiation. 2000, Pubmed

Ababou, ATM-dependent phosphorylation and accumulation of endogenous BLM protein in response to ionizing radiation. 2000, Pubmed
Abraham, Cell cycle checkpoint signaling through the ATM and ATR kinases. 2001, Pubmed
Adams, Drosophila BLM in double-strand break repair by synthesis-dependent strand annealing. 2003, Pubmed
Bachrati, RecQ helicases: suppressors of tumorigenesis and premature aging. 2003, Pubmed
Bartek, CHK2 kinase--a busy messenger. 2001, Pubmed
Beamish, Functional link between BLM defective in Bloom's syndrome and the ataxia-telangiectasia-mutated protein, ATM. 2002, Pubmed
Casper, ATR regulates fragile site stability. 2002, Pubmed
Cobb, DNA polymerase stabilization at stalled replication forks requires Mec1 and the RecQ helicase Sgs1. 2003, Pubmed
Costanzo, Mre11 protein complex prevents double-strand break accumulation during chromosomal DNA replication. 2001, Pubmed , Xenbase
Davies, Phosphorylation of the Bloom's syndrome helicase and its role in recovery from S-phase arrest. 2004, Pubmed
Dunø, Genetic analysis of the Saccharomyces cerevisiae Sgs1 helicase defines an essential function for the Sgs1-Top3 complex in the absence of SRS2 or TOP1. 2000, Pubmed
Enomoto, Functions of RecQ family helicases: possible involvement of Bloom's and Werner's syndrome gene products in guarding genome integrity during DNA replication. 2001, Pubmed
Franchitto, Bloom's syndrome protein is required for correct relocalization of RAD50/MRE11/NBS1 complex after replication fork arrest. 2002, Pubmed
Frei, The yeast Sgs1p helicase acts upstream of Rad53p in the DNA replication checkpoint and colocalizes with Rad53p in S-phase-specific foci. 2000, Pubmed
Guo, Requirement for Atr in phosphorylation of Chk1 and cell cycle regulation in response to DNA replication blocks and UV-damaged DNA in Xenopus egg extracts. 2000, Pubmed , Xenbase
Guo, Response of Xenopus Cds1 in cell-free extracts to DNA templates with double-stranded ends. 2000, Pubmed , Xenbase
Hekmat-Nejad, Xenopus ATR is a replication-dependent chromatin-binding protein required for the DNA replication checkpoint. , Pubmed , Xenbase
Hu, Evidence for BLM and Topoisomerase IIIalpha interaction in genomic stability. 2001, Pubmed
Imamura, Bloom helicase is involved in DNA surveillance in early S phase in vertebrate cells. 2001, Pubmed
Imamura, The human Bloom syndrome gene suppresses the DNA replication and repair defects of yeast dna2 mutants. 2003, Pubmed
Johnson, Association of the Bloom syndrome protein with topoisomerase IIIalpha in somatic and meiotic cells. 2000, Pubmed
Jones, XRad17 is required for the activation of XChk1 but not XCds1 during checkpoint signaling in Xenopus. 2003, Pubmed , Xenbase
Kobayashi, Focus-formation of replication protein A, activation of checkpoint system and DNA repair synthesis induced by DNA double-strand breaks in Xenopus egg extract. 2002, Pubmed , Xenbase
Kumagai, Claspin, a novel protein required for the activation of Chk1 during a DNA replication checkpoint response in Xenopus egg extracts. 2000, Pubmed , Xenbase
Kumagai, The Xenopus Chk1 protein kinase mediates a caffeine-sensitive pathway of checkpoint control in cell-free extracts. 1998, Pubmed , Xenbase
Kumagai, Repeated phosphopeptide motifs in Claspin mediate the regulated binding of Chk1. 2003, Pubmed , Xenbase
Lee, Claspin, a Chk1-regulatory protein, monitors DNA replication on chromatin independently of RPA, ATR, and Rad17. 2003, Pubmed , Xenbase
Liao, The function of Xenopus Bloom's syndrome protein homolog (xBLM) in DNA replication. 2000, Pubmed , Xenbase
Liu, Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. 2000, Pubmed
Lupardus, A requirement for replication in activation of the ATR-dependent DNA damage checkpoint. 2002, Pubmed , Xenbase
McGarry, Geminin, an inhibitor of DNA replication, is degraded during mitosis. 1998, Pubmed , Xenbase
Melo, A unified view of the DNA-damage checkpoint. 2002, Pubmed , Xenbase
Myung, Suppression of genome instability by redundant S-phase checkpoint pathways in Saccharomyces cerevisiae. 2002, Pubmed
O'Connell, The G2-phase DNA-damage checkpoint. 2000, Pubmed
Osborn, Checking on the fork: the DNA-replication stress-response pathway. 2002, Pubmed
Rassool, Constitutive DNA damage is linked to DNA replication abnormalities in Bloom's syndrome cells. 2003, Pubmed
Sharma, Stimulation of flap endonuclease-1 by the Bloom's syndrome protein. 2004, Pubmed
Stokes, DNA replication is required for the checkpoint response to damaged DNA in Xenopus egg extracts. 2002, Pubmed , Xenbase
Walter, Initiation of eukaryotic DNA replication: origin unwinding and sequential chromatin association of Cdc45, RPA, and DNA polymerase alpha. 2000, Pubmed , Xenbase
Wang, BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. 2000, Pubmed
Wu, The Bloom's syndrome gene product interacts with topoisomerase III. 2000, Pubmed
Wu, The Bloom's syndrome helicase stimulates the activity of human topoisomerase IIIalpha. 2002, Pubmed
Yanow, Xenopus Drf1, a regulator of Cdc7, displays checkpoint-dependent accumulation on chromatin during an S-phase arrest. 2003, Pubmed , Xenbase
You, The role of single-stranded DNA and polymerase alpha in establishing the ATR, Hus1 DNA replication checkpoint. 2002, Pubmed , Xenbase